Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02626455
Title Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Bayer
Indications

lymphoplasmacytic lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Vincristine Sulfate

Prednisone

Aldoxorubicin + Cyclophosphamide + Prednisone + Rituximab + Vincristine Sulfate

Copanlisib

Bendamustine + Rituximab

Rituximab

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.